Lysozyme loaded niosomes containing various molar ratios of two kinds of surfactants were prepared and the properties of these niosomal formulations were studied. The results revealed that the size of niosomes varied between 240.06 ± 32.41 and 895.2 ± 20.84 nm. Formulations with the lowest size and no precipitation had entrapment efficiencies ranging from 60.644 ± 3.310 to 66.333 ± 1.98%. Their controlled release profiles after 48 h were 15.67, 20.67 and 31.50%. After 2 months, the most stable formulation in terms of size, PDI, zeta potential, and entrapment efficiency was used to study the secondary structures of lysozyme in niosomal and free forms. Lysozyme loaded niosome and lysozyme adsorbed on the surface of niosome fell into one category in terms of the formation of α-helix,β -sheet, and turn structures. This study suggests that niosomes could be a promising delivery system for lysozyme with prolonged release profiles, which can be used in pharmaceutical and food industries.
Similar content being viewed by others
References
J. Manosroi, W. Lohcharoenkal, F. Gotz, et al., J. Pharm. Sci., 100, 1525 (2011).
S. Moghassemi, A. Hadjizadeh, A. Hakamivala, and K. Omidfar, AAPS PharmSciTech, 18, 34 (2017).
V. Akbari, D. Abedi, A. Pardakhty, and H. Sadeghi-Aliabadi, Avicenna J. Med. Biotechnol., 7, 69 (2015).
A. Manosroi, P. Khanrin, R. G. Werner, et al., J. Microencaps., 27, 272 (2010).
A. Pardakhty, J. Varshosaz, and A. Rouholamini, Int. J. Pharm. (Amsterdam, Neth.), 328, 130 (2007).
L. Tavano, R. Muzzalupo, L. Mauro, et al., Langmuir, 29, 12638 (2013).
C.-O. Rentel, J. Bouwstra, B. Naisbett, and H. Junginger, Int. J. Pharm. (Amsterdam, Neth.), 186, 161 (1999).
S. M. Niemiec, C. Ramachandran, and N. Weiner, Pharm. Res., 12, 1184 (1995).
A. Manosroi, W. Lohcharoenkal, F. Gotz, et al., J. Biomed. Nanotechnol., 7, 366 (2011).
J. Brewer and J. Alexander, Immunology, 75, 570 (1992).
S. Murdan, G. Gregoriadis, and A. T. Florence, Eur. J. Pharm. Sci., 8, 177 (1999).
S.-I. Park and S. M. Yoe, Animal Cells Systems, 16, 455 (2012).
L. Callewaert and C. W. Michiels, J. Biosci., 35, 127 (2010).
O. S. A. Abed, C. Chaw, L. Williams, and A. A. Elkordy, Sci. Rep., 8, 13158 (2018).
H. Yoshida, C.-M. Lehr, W. Kok, et al., J. Control. Release, 21, 145 (1992).
R. Rochdy Haj-Ahmad, A. Ali Elkordy, and C. Shu Chaw, Curr. Drug Deliv., 12, 628 (2015).
The HLB System: a Time-Saving Guide to Emulsifier Selection, ICI Americas Inc. (1984).
V. B. Junyaprasert, P. Singhsa, J. Suksiriworapong, and D. Chantasart, Int. J. Pharm. (Amsterdam, Neth.), 423, 303 (2012).
N. Bharti, S. Loona, and M. Khan, Int. J. Pharm. Sci. Rev. Res., 12, 67 (2012).
S. Taymouri and J. Varshosaz, Adv. Biomed. Res., 5, 48 (2016).
M. Hope, M. Bally, L. Mayer, et al., Chem. Phys. Lipids, 40, 89 (2016).
M. M. El-Sayed, A. K. Hussein, H. A. Sarhan, and H. F. Mansour, Drug Dev. Ind. Pharm., 43, 902 (2017).
N. J. Kruger, The Bradford method for protein quantitation, in: The Protein Protocols Handbook, Springer (2002), p. 15.
D. Charnvanich, N. Vardhanabhuti, and P. Kulvanich, AAPS PharmSciTech, 11, 832 (2010).
A. Manosroi, P. Wongtrakul, J. Manosroi, et al., Colloids Surf. B, 30, 129 (2003).
C. Bernsdorff, A. Wolf, R. Winter, and E. Gratton, Biophys. J., 72, 1264 (1997).
P. Balakrishnan, S. Shanmugam,W. S. Lee, et al., Int. J. Pharm. (Amsterdam, Neth.), 377, 1 (2009).
C. S. Chaw and K. Y. Ah Kim, Pharmaceutical development and technology 2013, 18, 667.
T. Yoshioka, B. Sternberg, and A. T. Florence, Int. J. Pharm. (Amsterdam, Neth.),105, 1 (1994).
S. Moghassemi, E. Parnian, A. Hakamivala, et al., Mater. Sci. Eng. C, 46, 333 (2015).
A. Y. Waddad, S. Abbad, F. Yu, et al., Int. J. Pharm. (Amsterdam, Neth.), 456, 446 (2013).
S. McLaughlin, G. Szabo, and G. Eisenman, J. Gen. Pphysiol., 58, 667 (1971).
A. Manosroi and K. Bauer, Drug Dev. Ind. Pharm., 15, 2531 (1989).
M. Raslan, J. Life Med., 1, 15 (2013).
M. Mokhtar, O. A. Sammour, M. A. Hammad, and N. A. Megrab, Int. J. Pharm. (Amsterdam, Neth.)., 361, 104 (2008).
J. Varshosaz, A. Pardakhty, V.-I. Hajhashemi, and A. R. Najafabadi, Drug Deliv., 10, 251 (2003).
H. S. Barakat, I. A. Darwish, L. K. El-Khordagui, and N. M. Khalafallah, Drug Dev. Ind. Pharm., 35, 631 (2009).
A. L. Weiner, Adv. Drug Deliv. Rev., 3, 307 (1989).
K. Ruckmani and V. Sankar, AAPS PharmSciTech, 11, 1119 (2010).
S. Dash, P. N. Murthy, L. Nath, and P. Chowdhury, Acta Pol. Pharm., 67, 217 (2010).
S. Kamboj, V. Saini, and S. Bala, Sci. World J., 2014, 1 (2014).
I. F. Uchegbu and S. P. Vyas, Int. J. Pharm. (Amsterdam, Neth.)., 172, 33 (1998).
A. Balasubramaniam, V. Anil Kumar, and K. Sadasivan Pillai, Drug Dev. Ind. Ppharm., 28, 1181 (2002).
M. Lawrence, S. Chauhan, S. Lawrence, and D. Barlow, STP Pharma Sci., 6, 49 (1996).
M. Seras-Cansell, M. Ollivon, and S. Lesieur, STP Pharma Sci., 6, 12 (1996).
E. Moazeni, K. Gilani, F. Sotoudegan, A. Pardakhty, et al., J. Microencaps., 27, 618 (2010).
A. Pardakhty, E. Moazeni, J. Varshosaz, et al., DARU J. Pharm. Sci., 19, 404 (2011).
Acknowledgements
This project was financially supported by a scholarship of education center of the Pasteur Institute of Iran to SS, PhD student.
Conflict of Interest
Authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sadeghi, S., Ehsani, P., Cohan, R.A. et al. Design and Physicochemical Characterization of Lysozyme Loaded Niosomal Formulations as a New Controlled Delivery System. Pharm Chem J 53, 921–930 (2020). https://doi.org/10.1007/s11094-020-02100-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-020-02100-6